메뉴 건너뛰기




Volumn 138, Issue 5, 2001, Pages 752-755

Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; THIOMERSAL;

EID: 0035013432     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.112896     Document Type: Article
Times cited : (11)

References (18)
  • 1
    • 0026430024 scopus 로고
    • Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
    • (1991) MMWR Morb Mortal Wkly Rep , vol.40 , pp. 1-25
  • 7
    • 0033538377 scopus 로고    scopus 로고
    • Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service
    • (1999) MMWR Morb Mortal Wkly Rep , vol.48 , pp. 563-565
  • 8
    • 0032884305 scopus 로고    scopus 로고
    • Thimerosal in vaccines - An interim report to clinicians
    • American Academy of Pediatrics, Committees on Infectious Diseases and Environmental Health
    • (1999) Pediatrics , vol.104 , pp. 570-574
  • 10
    • 0033543276 scopus 로고    scopus 로고
    • Notice to readers: Availability of hepatitis B vaccine that does not contain thimerosal as a preservative
    • (1999) MMWR Morb Mortal Wkly Rep , vol.48 , pp. 780-782
  • 11
    • 0001887441 scopus 로고    scopus 로고
    • United States 1998 MMWR, Prevention Summary of notifiable diseases
    • (1999) Morb Mortal Wkly Rep , vol.47 , pp. 1-93


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.